Treatments for Rare central precocious puberty
FDA-approved drugs, patient assistance programs, and travel grants tracked on UniteRare for this condition.
ℹ
Treatment data is extracted from FDA drug labels, DailyMed, and openFDA through automated and AI-assisted pipelines that read both structured records and unstructured label text.
Report missing dataFDA-approved treatments (5)
- Lupron Depot-PedLeuprolide acetateAbbVie Endocrine Inc.Approved Apr 2023
- Triptodurtriptorelin pamoateArbor Pharmaceuticals, LLCApproved Jun 2017
- Supprelin LAHistrelinEndo Pharmaceuticals Solutions, Inc.Approved May 2007
- Synarel Nasal SolutionNafarelin acetateSyntex (USA), Inc.Approved Feb 1992
- Supprelin InjectionHistrelin acetateRoberts Pharmaceutical Corp.Approved Dec 1991
Patient support programs (3)
Copay cards, manufacturer assistance, and foundation grants. Verification status shown on each card.
Lupron Depot
AbbVie Inc.
Prostate Cancer, Endometriosis, and Uterine Fibroids
Unverified — confirm before calling
copay card
Copay CardPatient Assistance
Accepting applications
Supprelin Injection
Roberts Pharmaceutical Corp.
Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications
Synarel Nasal Solution
Syntex (USA), Inc.
Unverified — confirm before calling
copay card
copay assistancePatient Assistance
Accepting applications